Accelerating Innovation Across Cell Therapies, Viral Vectors, Oligonucleotides and mRNA Delivery Workshop
Presented by Reni Kitte, Research Associate, PhD Candidate, Fraunhofer Institute for Cell Therapy and Immunology IZI (Fraunhofer IZI) Margherita Neri, Vector Process Development Director, AGC Biologics Dr. Barrie Cassey, Technology Lead – MMIC, Dr. Claire MacLeod, Grand Challenge Lead – Oligo Manufacturing at CPI Dr. Maribel Lara Chica, Head of Manufacturing of the Lentiviral Vector Platform for CAR-T Cell Therapy / Postdoctoral Research Scientist at IBiS
Join leaders in genomic medicine to discover the latest advancements in cell therapy, viral vectors, oligonucleotides and mRNA delivery. You’ll also have the opportunity to hear from therapeutic developers collaborating with Cytiva to explore how the organization is helping customers bring innovations to market.
Bring your questions for a live Q&A!
Agenda:
Introduction to the session and genomic medicine offerings from Cytiva
Lipid nanoparticle (LNP)-mediated mRNA delivery for transient CAR T cell engineering
Presenter: Reni Kitte, Research Associate, PhD Candidate, Fraunhofer Institute for Cell Therapy and Immunology IZI (Fraunhofer IZI)
Building tools that shorten your AAV and LVV timelines (30 minutes)
Presenter: Margherita Neri, Vector Process Development Director, AGC Biologics
Innovation in oligonucleotide manufacture
Presenters: Dr. Barrie Cassey, Technology Lead – MMIC, Dr. Claire MacLeod, Grand Challenge Lead – Oligo Manufacturing at CPI
Title TBC
Presenter: Dr. Maribel Lara Chica, Head of Manufacturing of the Lentiviral Vector Platform for CAR-T Cell Therapy / Postdoctoral Research Scientist at IBiS